Our Products

Bright-line™ (HVBN)

Coupled with our patented hand-held piezoelectric transducer, the Bright-line™ core biopsy needle provides unrivalled visualisation during ultrasound guidance in colour Doppler or Power mode. Even at challenging angles and deep tissue locations, clinicians and patients alike can benefit from increased accuracy and safety during ultrasound-guided core needle biopsy procedures.

  • Bright-line Biopsy System is CE marked and approved for sale and use within those countries recognising the CE award. The Bright-line Biopsy System is a Class IIa Medical Device intended for transient use, in accordance with Annex IX, Rule 6 and Rule 11 of EC Council Directive 93/42/EEC concerning medical devices as amended by Directive 2007/47/EC.

    ** The Bright-line Biopsy System is not currently approved for sale or use in the USA.

The HyPerfuse Needle™ revolutionary drug delivery technology means therapeutic anti-cancer treatments can be injected intratumourally, with perfusion and deposition rates never seen before. Active Needle Technology has demonstrated statistically and clinically significant improvements in intratumoural drug perfusion and deposition rates, and this effect has been replicated in pre-clinical studies in tumour bearing murine models, working with practising oncologists in association with a UK university. 9

A recent UK pre-clinical study confirmed that oncolytic drug delivery with our HyPerfuse Needle™ intratumoural delivery device resulted in vastly superior rates of cancer cell death when compared to the same drug using a standard needle.9

HyPerfuse  Needle™

  • This represents a step change in drug delivery technology. Finally, a novel device to compliment and optimise the performance of therapeutics and biologics; a solution to poor drug efficacy attributed to standard intratumoural delivery techniques and limited dispersion profiles.

    As an ultrasonic device, HyPerfuse Needle™ also offers unparalleled visualisation during targeted intratumoural delivery of small molecules, peptides, viruses, nanoparticles, vesicles and biologics, with an unprecedented distribution profile throughout the lesion.

    *HyPerfuse Needle™ is in development and is not yet cleared for sale or use.

Tranquill®

Our proprietary technology allows Tranquill® to offer the patient a uniquely low pain medical or cosmetic tattooing experience. By utilising Active Needle’s ultrasonic platform, patients can benefit from significantly less trauma to their skin during tattooing, improving the immediate post-procedure appearance and expediting the healing process.

This project was supported by grants from Innovate UK.

  • *Tranquill® is currently under development and not yet available for sale or use.

Active Needle Benefits






Unrivalled
Visibility

Ultrasonic technology provides unrivalled needle visibility during ultrasound guidance in Doppler mode, helping the operator to avoid critical deep-tissue structures.






Reduced
Pain

Vastly reduced needle penetration forces, especially during the initial skin puncture, can result in less pain and trauma to tissue and an improved patient experience.






Less
Deflection

Ultrasonic vibration facilitates more efficient needle-tip penetration through tissue interfaces, even at challenging angles and deeper anatomical locations. This can lead to more accurate placement.






Enhanced
Therapeutics

Ultrasonic intratumoural delivery can significantly enhance perfusion and deposition rates of a variety of therapeutic agents.